Regulatory T (Treg) and T helper 17 (Th17) cells were recently proposed to be reciprocally regulated during differentiation. To understand the underlying mechanisms, we utilized a Th17 reporter mouse with a red fluorescent protein (RFP) sequence inserted into the interleukin-17F (IL-17F) gene. Using IL-17F-RFP together with a Foxp3 reporter, we found that the development of Th17 and Foxp3 + Treg cells was associated in immune responses. Although TGF-b receptor I signaling was required for both Foxp3 and IL-17 induction, SMAD4 was only involved in Foxp3 upregulation. Foxp3 inhibited Th17 differentiation by antagonizing the function of the transcription factors RORgt and RORa. In contrast, IL-6 overcame this suppressive effect of Foxp3 and, together with IL-1, induced genetic reprogramming in Foxp3 + Treg cells. STAT3 regulated Foxp3 downregulation, whereas STAT3, RORg, and RORa were required for IL-17 expression in Treg cells. Our data demonstrate molecular antagonism and plasticity of Treg and Th17 cell programs.
SUMMARY
Regulatory T (Treg) and T helper 17 (Th17) cells were recently proposed to be reciprocally regulated during differentiation. To understand the underlying mechanisms, we utilized a Th17 reporter mouse with a red fluorescent protein (RFP) sequence inserted into the interleukin-17F (IL-17F) gene. Using IL-17F-RFP together with a Foxp3 reporter, we found that the development of Th17 and Foxp3 + Treg cells was associated in immune responses. Although TGF-b receptor I signaling was required for both Foxp3 and IL-17 induction, SMAD4 was only involved in Foxp3 upregulation. Foxp3 inhibited Th17 differentiation by antagonizing the function of the transcription factors RORgt and RORa. In contrast, IL-6 overcame this suppressive effect of Foxp3 and, together with IL-1, induced genetic reprogramming in Foxp3
INTRODUCTION

Naive CD4
+ helper T (Th) cells, upon encountering their cognate antigens presented on professional antigen-presenting cells (APCs), differentiate into effector cells that are characterized by their cytokine production profiles and immune-regulatory functions. In addition to Th1 and Th2 cells (Dong and Flavell, 2000) , a third subset of effector Th cells, Th17, has been identified; these produce IL-17, IL-17F, and IL-22 and regulate inflammatory responses by tissue cells (Dong, 2008) . Th17 cell differentiation in mouse is initiated by TGF-b and IL-6. Recently, IL-21 was reported as an autocrine factor induced by IL-6 to regulate Th17 cell differentiation. STAT3, downstream of IL-6 and IL-21, is essential for RORgt and RORa expression and Th17 cell differentiation (Laurence et al., 2007; Yang et al., 2007) . STAT3 may function by regulating the expression of two orphan nuclear receptors, RORgt and RORa, in developing Th17 cells (Ivanov et al., 2006; Yang et al., 2008b) .
Thymus-derived natural regulatory T (nTreg) cells represent a unique subpopulation of CD4 + T cells that inhibit T cell proliferation and autoimmune responses (Wing et al., 2006) . The hallmark of nTreg cells is the expression of Foxp3 transcription factor, which is required for maintaining Treg cell function (Williams and Rudensky, 2007) . TGF-b has been shown to maintain peripheral nTreg cells; its deficiency leads to development of early lethal autoimmunity (Marie et al., 2005; Shull et al., 1992) . Moreover, in the presence of TGF-b, Foxp3 can be also induced in naive T cells in the periphery, and the resulting inducible Treg (iTreg) cells exhibit a suppressive phenotype similar to that in nTreg cells (Wing et al., 2006) . As describe above, TGF-b is required for regulation of nTreg and iTreg cells, and it is also involved in Th17 cell differentiation. Thus, there is not only functional antagonism between Th17 and Treg cells in autoimmunity, but also reciprocal regulation in the generation of these cells. Although TGF-b induces Foxp3 expression, IL-6 and IL-21 inhibit this regulation and together with TGF-b drive Th17 cell differentiation. The molecular mechanisms underlying this differential T cell fate decision initiated by cytokines is unclear. In the present study, we have analyzed the molecular interaction of Treg and Th17 cell genetic programs in response to cytokine regulation. To better address this question, we utilized a Th17 reporter mouse with a red fluorescent protein (RFP) coding sequence inserted into the IL-17F gene. Our data reveal intrinsic association of Th17 and Treg cell differentiation programs in activated T cells in vitro and in vivo. In addition, we have analyzed the genetic programming and reprogramming of Treg and Th17 cells. The results revealed the molecular antagonism of Treg and Th17 cell genetic programs and indicated the plasticity of T cell differentiation programs.
RESULTS
Generation and Characterization of an IL-17F-RFP Reporter Mouse
To better characterize Th17 cell differentiation, we generated an IL-17F reporter strain by insertion of a cassette containing an internal ribosome entry site (IRES)-driven red fluorescent protein (RFP) and a bovine growth hormone polyA tail into the 2 nd exon of the IL-17F gene through homologous recombination in murine embryonic stem cells (Yang et al., 2008a) . Heterozygous IL-17F-RFP (hereafter referred as Il17f rfp ) mice were first tested for the fidelity of RFP expression in reporting Th17 cells. Naive CD4 + CD25 À CD62L hi CD44 lo T cells were isolated from Il17f rfp mice by fluorescence-activated cell sorting (FACS) and differentiated under Th1, Th2, Th17, and iTreg conditions. Four days after activation, RFP was highly expressed in Th17 cells but not in Th1 and Th2 cells ( Figure 1A ). Notably, under iTreg condition, weak expression of RFP was also observed ( Figure 1A ), although IL-17 protein was not expressed (data not shown).
Because not all cells differentiated under Th17 cell conditions express RFP, we next sorted RFP + and RFP À subsets from the above Th17 culture by flow cytometry and then evaluated IL-17 and IL-17F expression by intracellular staining. In RFP + population, there was a substantial IL-17 and IL-17F double-producing subset and an IL-17F single expression subset ( Figure 1B ). Figure S1A available online). Th1-, Th2-, and iTreg-specific genes (Tbx21, Gata3, and Foxp3, respectively) were not highly expressed in the RFP + cells ( Figure S1A ).
Because IL-17F-RFP marks Th17 cells, we further utilized T cells from Il17f rfp mice to characterize the cytokine regulation of Th17 cell differentiation. Naive T cells isolated from Il17f rfp mice were activated in the presence or absence of IL-6, IL-21, or TGF-b or a combination of the cytokines. Unlike the neutral condition, IL-6 or TGF-b slightly increased the number of RFPexpressing cells ( Figure 1C ); in these cells, IL-17F was expressed at low amounts ( Figure S1B ). The combination of TGF-b with IL-6 or IL-21 greatly increased the frequency of RFP-expressing cells ( Figure 1C ). Cytokine staining revealed that IL-17F expression correlated well with RFP expression ( Figure S1B ). IL-17 expression also correlated with RFP expression under IL-6, TGF-b and IL-6, or TGF-b and IL-21 conditions but not under TGF-b stimulation ( Figure S1B ). Lamina propria was previously shown as a site where some T cells constitutively express IL-17 (Ivanov et al., 2006 Figure 2C ), suggesting that Th17 and Treg cells generated in vivo also share intrinsic common programs with those differentiated in vitro.
TGF-b Signaling Requirements during Th17 and iTreg
Cell Differentiation TGF-b regulates iTreg and, together with IL-6, Th17 cell differentiation, but the underlying signaling mechanism is unclear. For analysis of this, naive cells from C57BL/6 (B6) mice were 
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Interplays of Treg and Th17 Programs differentiated toward Th17 cells for 5 days, and an inhibitor of TGFbRI kinase activity, SB431542, was added at different time points during the Th17 cell differentiation. Inhibition of TGF-b signaling on day 0 or day 1 completely abolished IL-17 production ( Figure 3A ). Moreover, a 50% reduction in IL-17 production was observed after addition of the inhibitor on day 2, whereas no substantial inhibition was found on day 3 ( Figure 3A ). Real-time RT-PCR analysis also indicated decreased expression of IL-17, IL-17F, RORa, RORgt, and IL-23R mRNA in Th cells after addition of SB431542 on days 0 and 1 ( Figure 3B ). Similar to Th17 cell differentiation, TGF-b signaling was also required during the first 2 days after initiation of iTreg cell differentiation ( Figure 3C ). These data indicate that active TGF-b signaling is required during the first 2 days of Th17 and Treg cell differentiation. TGF-b receptor activation induces activation and phosphorylation of Smad2 and Smad3, which then bind to Smad4 and translocate to the nucleus (Feng and Derynck, 2005) . Therefore, we next investigated the role of Smad4 by using Smad4-deficient CD4 + T cells. Mice with Smad4 deletion in T cells were generated by breeding mice with floxed Smad4 (fl) alleles (Chu et al., 2004) with CD4-Cre mice (Lee et al., 2001 S4C ). Moreover, Smad4-deficient nTreg were as suppressive as wild-type nTreg ( Figure 3D ). Figure 3D ). Thus, Smad4 is not required for nTreg cell development and suppressive activity or naive T cell suppression by nTreg cells. We next investigated whether Smad4 is required for iTreg or Th17 cell differentiation by stimulating naive Th cells under iTreg or Th17 conditions. Smad4-deficient Th cells showed reduced Foxp3 expression compared to wild-type T cells upon iTreg induction ( Figure 3E ). However, upon Th17 cell differentiation, comparable numbers of IL-17-producing cells were observed between Smad4-deficient and wild-type T cells ( Figure 3F ), indicating that Smad4 is differentially required for iTreg and Th17 cell differentiation. Further in vivo analysis showed no difference in IL-17, IL-17F, and IL-22 production between wild-type and Smad-4 deficient T cells after KLH immunization ( Figure S4D ). Thus, although active TGF-b signaling regulates both iTreg and Th17 cell differentiation, different downstream molecules may be utilized to regulate the development of these two T cell lineages.
Regulation of Th17 Cell Differentiation by Foxp3
Because TGF-b induces the expression of Foxp3, we next assessed Foxp3 function in Th17 cell differentiation. First, we overexpressed Foxp3 in T cells by retroviral transduction. Naive CD4 + T cells from OT-II mice were activated with Ova peptide and irradiated splenic APCs under Th17 conditions. On day 1, activated T cells were infected with bicistronic retroviruses containing an IRES-GFP. Four days after infection, IL-17-and Foxp3-expressing cells were determined by intracellular staining. Compared to cells infected with a control virus, Foxp3 overexpression greatly decreased the percentage of IL-17-secreting cells ( Figure 4A ). We then sorted GFP À and GFP + cells from the above experiment, and their gene expression profiles were assessed with real-time RT-PCR. In comparison with cells infected with the control virus, Foxp3 overexpression greatly reduced IL-17, IL-17F, and IL-21 mRNA expression, whereas RORgt and RORa expression remained the same ( Figure 4B ). These (Yang et al., 2008b) in the presence or absence of RORa or RORgt with or without Foxp3-expressing vector. Whereas RORa or RORgt alone induced luciferase activity, coexpression of Foxp3 markedly reduced their activity ( Figures 4C-4F and Figures S5D-S5F) . Because neither the IL-17 promoter nor the CNS2 element contains a detectable Foxp3-binding site, we analyzed whether Foxp3 DNA binding or homodimerization is required for its ability to suppress RORa or RORgt function. Foxp3DFKH, a Foxp3 mutant lacking the forkhead domain but with the SV40 nuclear localization sequence (Lee et al., 2008) , or Foxp3DE250, a Foxp3 mutant that possesses a single amino acid deletion in the leucine-zipper domain and thus cannot homodimerize or bind to DNA well (Chae et al., 2006) , was coexpressed with RORgt. These two mutants were found to still inhibit RORgt-driven luciferase activity ( Figure 4C ). Foxp3DE250 and Foxp3DFKH also inhibited Th17 cell differentiation in primary T cells (data not shown). Furthermore, Foxp3 also directly inhibited RORg activation of a RORE reporter in a dose-dependent manner (data not shown). Our data together indicate that Foxp3 overexpression inhibits RORgt activity independently of Foxp3 homodimerization or DNA binding. Nuclear receptors bind to coactivators or corepressors through interaction between the AF2 domains of the nuclear receptors with LxxLL motifs in coactivators and/or corepresors. To understand how Foxp3 inhibits ROR function, we utilized a mammalian two-hybrid system, in which luciferase reporter activity is activated upon binding of RORg to an LxxLL-containing peptide EBIP96 derived from SRC-1 coactivator (Kurebayashi et al., 2004) . Interestingly, Foxp3 inhibited, in a dose-dependent manner, the binding of RORg to the LxxLL-containing peptide ( Figure S5A ), indicating that Foxp3 may interfere with the association of RORg with its coactivator. Given that Foxp3 contains an LQALL sequence in its second coding exon, we hypothesized that Foxp3 might interact with both RORa and RORgt and (H) Naive WT or Scurfy OT-II T cells were stimulated with the indicated cytokines and neutralizing antibodies. Four days later, cells were assessed for IFN-g and IL-17 production by intracellular staining. The data represent at least three independent experiments with consistent results.
compete with coactivators for ROR binding. We therefore examined the interaction of RORa with wild-type Foxp3 and several Foxp3 mutants by using coimmunoprecipitation. Although Foxp3 and RORa were found to associate when they were coexpressed in 293T cells, a Foxp3 mutant carrying a mutation in an LQALL motif (LL-AA mutant) exhibited a greatly decreased association with RORa ( Figure S5B ). In addition, a mutant Foxp3 containing only amino acids encoded by exons 1 and 2, which include the LQALL motif but no DNA binding or dimerization domain, inhibited RORg transcriptional activity ( Figure S5C ), suggesting that LQALL in Foxp3 may inhibit RORa or RORg interaction with a coactivator.
We further tested the function of Foxp3 LQALL motif by use of the LL-AA mutant. In the mammalian two-hybrid system, the Foxp3 LL-AA mutant had reduced ability to inhibit the binding of RORg to EBIP96, compared to Foxp3 wild-type ( Figure S5A ). To evaluate the functional implication of this decreased inhibitory activity by the Foxp3 LL-AA mutant, we analyzed whether lack of the LxxLL domain impairs Foxp3 ability to inhibit activation of IL-17 transcription by RORs. We observed a non-statistically significant dose-dependent downregulation of luciferase activity by Foxp3 LL-AA mutant when coexpressed with RORgt or RORa ( Figure 4D and Figure S5D ). Thus, these results indicate that the Foxp3 LxxLL domain is important for binding to RORs, but lack of this domain inhibits but does not completely abolish Foxp3-mediated interference of ROR activity.
Foxp3 has been previously shown to bind to TIP60 and HDAC7 (Li et al., 2007) . To further explore which additional domain of Foxp3 might be required for its inhibitory activity on RORs, we utilized a Foxp3 D105-190 mutant that does not bind to TIP60-HDAC7 complex (Li et al., 2007) . Interestingly, although this mutant binds to RORa well when they were coexpressed in 293T cells (Figure S5B ), the ability of Foxp3 to inhibit transcriptional activity of RORgt was partially reversed by lack of TIP60-HDAC7-binding domain ( Figure 4E and Figure S5E ). Moreover, lack of both LxxLL and TIP60-HDAC7 domains completely impaired Foxp3 inhibition of RORgt or RORa transcriptional activity ( Figure 4F and Figure S5F ). For further demonstration of the role of these domains in inhibition of Th17 cell differentiation, naive OT-II cells were infected with Foxp3 constructs under Th17-polarizing conditions, and IL-17 production was evaluated by intracellular staining. Overexpression of wildtype, LL-AA, or D105-190 Foxp3 mutants greatly decreased the percentage of IL-17-secreting cells compared to cells infected with vector alone ( Figure 4G ). However, Foxp3 lacking both the LxxLL and TIP60-HDAC7 domains was not able to inhibit IL-17 production ( Figure 4G ), further demonstrating that Foxp3 inhibits the activity of RORa and RORg by direct binding with its LQALL domain and/or by recruiting the TIP60-HDAC7 complex.
To further assess the function of Foxp3 in Th17 cell differentiation, we bred OT-II T cell receptor (TCR) transgenic mice with Scurfy mice, which have a point mutation in Foxp3 gene. Naive CD4 + T cells from wild-type or Scurfy OT-II mice were stimulated with Ova peptide and irradiated splenic APCs in the presence of different cytokine stimuli. Similar to wild-type T cells, Scurfy OT-II cells did not produce IL-17 in the present of TGF-b alone (Figure 4H, Figure S6A ), indicating that Foxp3 deficiency was not sufficient to convert iTreg into Th17 cells and suggesting that IL-6 signaling is required for Th17 cell differentiation and does not just function by suppressing Foxp3 expression. When they were activated in the presence of TGF-b and IL-6, reduced production of IL-17 and IL-17F and enhanced IFN-g was observed in the Scurfy T cells ( Figure 4H, Figure S6A ). However, addition of blocking antibodies to IFN-g and IL-4 together with TGF-b and IL-6 resulted in comparable amounts of IL-17 and IL-17F production in wild-type and Scurfy Th cells ( Figure 4H , Figure S6A ). Real-time PCR analysis also indicated decreased expression of IL-17, IL-17F, and RORgt mRNA in Scurfy-deficient Th cells compared to wild-type counterparts when they were activated by TGF-b and IL-6, whereas blocking antibodies to IL-4 and IFN-g restored their IL-17, IL-17F, and RORgt mRNA expression ( Figure S6B ). Taken together, these results indicate that lack of Foxp3 expression in T cells leads to increased Th1 cell differentiation and does not enhance Th17 cell differentiation. The latter is probably due to an inhibitory effect by IL-6 on Foxp3 expression and function during Th17 cell differentiation.
Conversion of iTreg to Th17 Cells
Because TGF-b induces Foxp3 on its own whereas IL-6 overrides this differentiation process and skews T cells toward Th17 lineage, we next analyze whether IL-6 is able to inhibit precommitted Foxp3-mediated Treg programs. Naive CD4 + T cells from Foxp3-GFP reporter mice were activated together with TGF-b, IL-2, and neutralizing antibodies against IL-4 and IFN-g for 5 days, and Foxp3-GFP + cells were sorted and restimulated with various cytokines for 4 days. Foxp3-GFP and IL-17 expression was determined by flow cytometry. Although iTreg cells quickly lost Foxp3 expression in the presence or absence of IL-2 as previously reported (Selvaraj and Geiger, 2007) , IL-6 stimulation alone, or in combination with IL-1 and IL-23, enhanced Foxp3 downregulation but only slightly increased IL-17 production ( Figure 5A ). However, when we stimulated iTreg cells with TGF-b, Foxp3 expression was sustained ( Figure 5A ). In the presence of TGF-b, IL-6 alone or in combination with IL-1 and IL-23 markedly downregulated Foxp3 expression and increased IL-17 production ( Figure 5A ). Real-time RT-PCR analysis of other Th17-specific genes demonstrated substantially enhanced expression of IL-22, IL-23R, and RORgt mRNA in iTreg cells stimulated with IL-6, IL-1, and IL-23 ( Figure 5B ). However, the expression of these genes was not significantly increased in the presence of TGF-b ( Figure 5B ). Thus, these results indicate that the Treg program is turned off by IL-6 and that iTreg cells can be reprogrammed to Th17 cells in the presence of TGF-b and IL-6. Recently, all-trans retinoic acid (RA) was shown to inhibit the induction of proinflammatory Th17 cells but to promote anti-inflammatory Treg cell differentiation (Mucida et al., 2007 Figure 5C ). Thus, although iTreg cells developed in the presence of RA were still susceptible to Foxp3 downregulation, they were resistant to induction of the Th17 program.
Cytokine-Driven Conversion of nTreg Cells into Th17 Cells
Because iTreg cells, even 5 days after differentiation, can be reprogrammed to Th17 cells, we asked whether nTreg cells could be converted. FACS-sorted CD4 + CD25 + T cells from B6 mice, which contained more than 99% Foxp3-expressing T cells (data not shown), were activated with plate-bound anti-CD3 and anti-CD28 in the presence of IL-6 for 4 days. Addition of IL-6 to nTreg cells resulted in expression of IL-17 and downregulation of Foxp3 expression ( Figure 6A ). Similarly, when nTreg cells from the IL-17F-RFP reporter mice, which did not express RFP after sorting (data not shown), were cultured as above, RFP was induced ( Figure 6B ). This finding indicates that IL-17F was also induced by IL-6 in nTreg cells. Next, for determination of whether IL-17-IL-17F-expressing T cells were suppressive, RFP + and RFP À cells ( Figure 6B ) were FACS sorted and subjected to a suppression assay. Similar to nonmanipulated nTreg cells, RFP À cells inhibited the proliferation of naive T cells ( Figure 6C Figure 6D ). Because some nTreg cells are reactive with MOG peptides (Korn et al., 2007) Figure 6D ). However, in CD45.2 + populations, there was significant downregulation of Foxp3 expression ( Figure 6D ). In addition, IL-17 expression was detected in Foxp3 À cells ( Figure 6D ). When cells were restimulated with PMA plus ionomycin, Foxp3 and IL-17 dual expressers were also observed ( Figure 6D ). This result indicates that in the presence of inflammatory signals, nTreg cells can differentiate into Th17 cells in vivo.
Regulation of nTreg Conversion to Th17 Cells
We further examined the regulation of Treg cell differentiation into Th17 cells by other cytokines by using Treg cells purified from Foxp3-GFP reporter mice. In addition to IL-6, IL-21 exerted similar regulation but was less potent ( Figure 7A ). IL-1 alone induced a small percentage of IL-17-producing cells but did not Figure 7A ). Thus, although TGF-b, IL-6, IL-21, and IL-1 regulate the induction of IL-17-producing cells, IL-6 seems most potent and unique in downregulating Foxp3 expression. nTreg cells from mesenteric lymph nodes could be also converted into Th17 cells upon activation in the presence of IL-6, IL-1, and IL-23 ( Figure S7A ). To rule out the possibility that the converted cells were iTreg generated in the periphery, we iso- 2000) mice (the latter is deficient in all RORg isoforms including RORgt) and from Rora sg/sg and Rora sg/sg Rorc À/À mice (Yang et al., 2008b) and their appropriate controls were stimulated with plate-bound anti-CD3 and anti-CD28 in the presence of various cytokines, and Foxp3 and IL-17 expression were determined by intracellular staining. STAT3-deficient nTreg cells failed to downregulate Foxp3 expression or express IL-17 ( Figure 7C ). In contrast, Rorc À/À nTreg cells downregulated Foxp3 expression but only expressed very low amounts of IL-17 when compared to their controls ( Figure 7D ). Compared to RORg deficiency, RORa mutant T cells exhibited moderate reduction in IL-17 expression but normal Foxp3 downregulation ( Figure S9 ). T cells defective in both RORa and RORg were also able to downregulate Foxp3 but had complete IL-17 deficiency ( Figure 7D ). Figure 7E ), indicating that autocrine IL-21 is not required for IL-6-mediated conversion of nTreg cells.
DISCUSSION
In this study, we have investigated the molecular interactions of the Treg and Th17 genetic programs ( Figure S10 ). Using an TGF-b plays an important role in the development, maintenance, and induction of regulatory T cells. Our mutagenesis analysis reveals that Foxp3 could compete with coactivator binding to RORs via two independent and nonexclusive mechanisms. Moreover, we found that Scurfy T cells, compared to their wild-type counterparts, exhibited reduced expression of Th17 cytokines and RORa and RORgt when stimulated with TGF-b and IL-6; this reduced expression was associated with increased Th1 cell differentiation. However, when IFN-g and IL-4 were blocked under the same conditions, restoration of Th17 cytokines and RORgt was observed. Therefore, lack of Foxp3 expression in T cells results in enhanced Th1 cell differentiation, but Foxp3, although transiently induced in some T cells undergoing Th17 development, is not required for Th17 cell lineage differentiation. Furthermore, because Scurfy T cells did not spontaneously develope into Th17 cells in the presence of TGF-b, it suggests that TGF-b signaling is not sufficient to drive Th17 cell differentiation. STAT3 downstream of IL-6 may be also required, which does not merely function by downregulating Foxp3. Our results thus further support the synergy of TGF-b and IL-6 in Th17 cell differentiation.
IL-6 inhibits TGF-b-dependent Foxp3 + Treg cell induction (Bettelli et al., 2006) . Our current study also indicates that IL-6 can reprogram fully differentiated iTreg and nTreg cells and redifferentiate them toward the Th17 lineage. By using reporter mice for Foxp3 and IL-17F, we found that the resulting cells express Th17-specific genes and lack suppressive function. This action by IL-6 is synergized by IL-1 and requires TGF-b. However, although TGF-b, IL-6, IL-21, and IL-1 regulate the induction of IL-17-producing cells, IL-6 seems most potent in downregulating Foxp3 expression. Terminally differentiated cells have been shown to be able to dedifferentiate and redifferentiate. For example, it was recently reported that mature B cells, when the Pax5 gene was deleted, were able to redifferentiate into T cells (Cobaleda et al., 2007) . Interestingly, it was previously observed that deletion of the Foxp3 gene in mature nTreg cells resulted in loss of suppressive function and upregulation of IL-17 and IL-21 expression (Williams and Rudensky, 2007) , suggesting that the suppression of Th17 gene expression and the maintenance of Treg programs both require Foxp3. Unlike these two cases, here we observe the proinflammatory cytokine milieu in both de-and redifferentiation of Treg cells. Our results are consistent with recent work by Xu et al., who found that Treg cells convert to Th17 cells when cultured with IL-6 in the absence of TGF-b (Xu et al., 2007) . These studies not only indicate the plasticity of Th cell differentiation programs but also have important implications. First, they suggest an alternative source of Th17 cells in vivo, i.e., derived from Foxp3 + nTreg and iTreg cells.
This pathway is potentially problematic because many Treg cells have autoreactive specificities (Hsieh et al., 2004) . Second, in future therapy using Treg cells against autoimmune diseases, suppression of inflammatory cytokines, especially IL-6, would be needed simultaneously to prevent them from redifferentiating into pathogenic Th17 cells. How STAT3 mediates Foxp3 downregulation by IL-6 remains to be determined. IL-6 induced Foxp3 mRNA downregulation in nTreg cells 24 and 48 hr after treatment (data not shown). In addition, we also found that in T cells transduced with Foxp3-expressing retroviruses, i.e., with exogenous promoters and untranslated regions, IL-6 downregulated Foxp3 protein expression (data not shown). Regardless of which mechanism, this important regulation will unleash the inhibitory function of Foxp3, thus allowing Th17 cell differentiation to occur. It is of note that although Foxp3 strongly inhibits Th17 cell differentiation, substantial number of T cells coexpressed Foxp3 and IL-17 and IL-17F in the early phase after IL-6 treatment. IL-17 and IL-17F expression was dependent on RORgt and RORa. How RORa and RORgt overcome Foxp3 expression in these cells remains to be understood. It is not clear at this stage whether Foxp3 and IL-17 dual-expresser cells are bipotential.
In summary, we demonstrate in this study molecular mechanisms of antagonistic regulation of Treg and Th17 programs, both of which depend on TGF-b. In addition, our data indicate the plasticity of nTreg and iTreg cells and the transcriptional pathways that convert them to the Th17 program. These results may be beneficial in our further understanding on the genetic programs underlying Th cell differentiation and maintenance, and have implications in immunotherapy. One may consider enhancing Treg generation and function in autoimmunity while converting regulatory T cells to effector T cells in cancer patients.
EXPERIMENTAL PROCEDURES
Mice C57BL/6, Rag1-deficient, and B6.SJL (CD45.1) mice were purchased from Jackson Laboratories. Smad4 fl/fl mice were kindly provided by M. Matzuk with permission of E. Robertson (Chu et al., 2004) , and these mice as well as Rorc À/À mice were described previously (Kurebayashi et al., 2000; Nurieva et al., 2007; Yang et al., 2008b) . Il17f rfp reporter was generated by insertion of an IRES-mRFP-polyA cassette into the exon 2 of the Il17f gene (Yang et al., 2008a) and maintained on a 129xB6 F1 background. Mice were housed in the specific pathogen-free (SPF) animal facility at M.D. Anderson Cancer Center, and the animal experiments were performed at the age of 6-10 weeks with protocols approved by Institutional Animal Care and Use Committee.
T Cell Differentiation CD4 + CD25 À CD62L hi CD44 lo cells were FACS sorted and stimulated and analyzed as described Yang et al., 2007) All-trans retinoic acid was purchased from Sigma and used at a 100 nM/ml concentration. Gene expression was examined with a Bio-Rad iCycler Optical System with the iQ TM SYBR green real-time PCR kit (Bio-Rad Laboratories). The data were normalized to Actb reference. The primers were previously described Yang et al., 2007) .
MOG Immunization and Induction of EAE
Female mice at 5-8 weeks of age were immunized subcutaneously at the dorsal flanks with 150 mg of MOG 35-55 peptide emulsified in CFA. Five days later, cells from spleens and draining lymph nodes of the immunized mice were isolated and restimulated with MOG for 24 hr, and RFP and GFP expression was assessed by flow cytometry. Induction of EAE was as described (Yang et al., 2008b) .
Transcription-Reporter Assay
RORg, RORa, wild-type Foxp3, Foxp3DE250, Foxp3DFKH/NLS, Foxp3LL-AA, were cloned into bicistronic retroviral vector pGFP-RV provided by K. Murphy that contains IRES-regulated GFP. The expression vectors were transfected into EL-4 cells with a luciferase construct containing IL-17 minimal promoter with CNS2 element (Yang et al., 2008b) . The dual-luciferase reporter system (Promega) was used to assay Firefly and Renilla luciferase activity in each sample. Renilla luciferase was used to normalize transfection efficiency and luciferase activity.
Two-Hybrid and RORE-Reporter Assay CHO cells were cotransfected with 0.1 mg of a luciferase reporter, 0.05 mg of a RORg-expressing vector, 0.1 mg of an LXXLL-motif-encoding vector pM-EBIP96, and Foxp3-expressing vectors as indicated with Fugene 6 transfection reagent (Roche, Indianapolis, IN). The luciferase reporter was (UAS)5-Luc, containing five copies of the GAL4 upstream-activating sequence (UAS) or (RORE)3-Luc, and the RORg-expressing vector is VP16-RORg or pZeoSV-RORg. Cells were incubated for 40 hr, and then luciferase activity was analyzed with a luciferase kit (Promega). Transfection efficiency was normalized by b-galactosidase activity.
Coimmunoprecipitation
Expression vectors encoding RORa, wild-type, or mutant Foxp3 molecules were transfected into 293 T cells. After 48 hr, cells were washed with ice-cold PBS and lysed in ice-cold lysis buffer (50 mM Tris-HCl [pH 8.0], 120 mM NaCl, 1% Nonidet P-40, 4 mM EDTA, 50 mM NaF, 1 mM Na3VO4, 2 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin A). Lysates were obtained by centrifugation and precleared with protein A-sepharose (Sigma-Aldrich) for 2 hr before 2 mg of anti-FLAG-M2 antibody (Sigma-Aldrich) was added. After incubation, protein A-Sepharose was added and immunoprecipitates were obtained by centrifugation. Equivalent amounts of protein from whole-cell lysates or immunoprecipitates were analyzed by western blot using anti-human and -mouse FOXP3 (eBioscience) or anti-FLAG-M2. Twenty-four hours after activation, cells were infected by retroviruses expressing Foxp3 or control empty vector (containing only IRES-GFP) and analyzed 4 days later as previously described (Yang et al., 2008b were FACS sorted and mixed at 1:10 ratio. These cells were intravenously transferred into syngenic Rag1 À/À mice (5 3 10 6 cells/mouse). The recipient mice were immunized subcutaneously with 150 mg of MOG 35-55 peptide emulsified in CFA. Five days later, lymphoid cells from spleens were isolated and restimulated with MOG for 24 hr in the presence of Golgi-stop for last 5 hr or PMA and Ionomycin and Golgi-stop for 5 hr. Cells were stained with PerCPCy5.5-conjugated anti-CD45.2 together with APC-conjugated anti-CD4 before they were analyzed by intracellular staining.
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